Elevated cholesterol precursors other than cholestanol can also be a hallmark for CTX
- 24 October 2008
- journal article
- case report
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 31 (S2) , 387-393
- https://doi.org/10.1007/s10545-008-0963-1
Abstract
Summary: Cerebrotendinous xanthomatosis (CTX) is an inborn error of bile acid synthesis in which hepatic conversion of cholesterol to cholic and chenodeoxycholic acids is impaired. Patients have abnormal bile alcohols in urine, normal to increased plasma cholesterol concentrations and increased concentrations of plasma cholestanol. Little is known about cholesterol precursors in CTX, however. We studied cholesterol and phytosterol profiles in two siblings with CTX during follow‐up. While cholesterol concentrations were low in both patients, plasma cholestanol was 6‐fold higher compared to control values. In addition, both siblings had a more than 100‐fold increase in 7‐dehydrocholesterol (7DHC) and 8‐dehydrocholesterol (8DHC). Lathosterol, lanosterol and sitosterol were increased in both patients while concentrations of desmosterol and campesterol were normal. In addition, plasma lathosterol/cholesterol ratios were significantly elevated. After treatment with chenodeoxycholate, both patients showed a marked decrease in cholestanol, 7DHC, 8DHC, lathosterol, lanosterol and sitosterol. In addition, the lathosterol/cholesterol ratio normalized, indicating that overall cholesterol synthesis was sufficiently suppressed. This study shows that elevated cholesterol precursors, other than cholestanol, can be a hallmark for CTX.Keywords
This publication has 31 references indexed in Scilit:
- Sterol parameters as markers of liver function in primary biliary cirrhosis before and after liver transplantationTransplant International, 2005
- Mutation analysis and description of sixteen RSH/Smith-Lemli-Opitz syndrome patients: Polymerase chain reaction-based assays to simplify genotypingAmerican Journal of Medical Genetics, 2000
- Clinical and molecular genetic characteristics of patients with cerebrotendinous xanthomatosisBrain, 2000
- Comparative effects of lovastatin and chenodeoxycholic acid on plasma cholestanol levels and abnormal bile acid metabolism in cerebrotendinous xanthomatosisMetabolism, 1994
- Combined treatment with chenodeoxycholic acid and pravastatin improves plasma cholestanol levels associated with marked regression of tendon xanthomas in cerebrotendinous xanthomatosisMetabolism, 1991
- Aneurysmal coronary artery disease in cerebrotendinous xanthomatosisThe American Journal of Cardiology, 1988
- Biosynthesis of bile acids in cerebrotendinous xanthomatosis. Relationship of bile acid pool sizes and synthesis rates to hydroxylations at C-12, C-25, and C-26.Journal of Clinical Investigation, 1985
- Long-Term Treatment of Cerebrotendinous Xanthomatosis with Chenodeoxycholic AcidNew England Journal of Medicine, 1984
- Bile alcohol metabolism in man. Conversion of 5beta-cholestane-3alpha, 7alpha,12alpha, 25-tetrol to cholic acid.Journal of Clinical Investigation, 1975
- Metabolism of β-sitosterol in manJournal of Clinical Investigation, 1970